# Personalized Health Association > A national 501(c)(4) advancing responsible, evidence-based personalized healthcare. Personalized Health Association works on federal and state healthcare policy affecting personalized and precision medicine. Its seven areas of focus are telemedicine and patient access, compounding, regenerative medicine, peptides and emerging therapies, hormonal and metabolic health, clinical research and evidence, and state patient-provider protection. Address: 1330 Foothill Rd, Ojai, CA 93023 Profile: https://www.linkedin.com/company/personalized-health-association/ Profile: https://www.instagram.com/personalizedhealthorg ## Start here - [Personalized Health Association](https://personalizedhealthassociation.org/): Healthcare policy advocacy for personalized medicine, at federal and state level. - [About](https://personalizedhealthassociation.org/about): How the organisation is structured, and the leadership and advisors behind it. - [Proof](https://personalizedhealthassociation.org/proof): How PHA brings policymakers, physicians and patients together on health policy. ## Advocacy - [Federal advocacy](https://personalizedhealthassociation.org/federal-advocacy): Telemedicine prescribing flexibilities expire December 31, 2026. PHA is advancing a permanent federal framework with a workable special registration. - [State advocacy](https://personalizedhealthassociation.org/state-advocacy): State legislatures, medical boards and pharmacy boards decide what providers may prescribe. How PHA engages before poor policy spreads across states. ## Areas of focus - [Areas of focus](https://personalizedhealthassociation.org/areas-of-focus): The seven policy areas PHA works on. Each links to a page on that subject. ## Publications and events - [Perspectives](https://personalizedhealthassociation.org/articles): Analysis and policy perspectives on regenerative medicine, physician-led research, telemedicine and men's health. - [Events](https://personalizedhealthassociation.org/events): Conferences and policy gatherings PHA attends, with dates and locations. ## Get involved - [Partner with PHA](https://personalizedhealthassociation.org/membership): For providers, telehealth organizations, compounding pharmacies and healthcare companies. - [Contact](https://personalizedhealthassociation.org/contact): Send a message to the organisation. ## Policy priorities - [Telemedicine & Patient Access](https://personalizedhealthassociation.org/priorities/telemedicine): Advancing durable policy that supports responsible virtual care, continuity for patients, and clear rules for providers. - [State Patient-Provider Protection](https://personalizedhealthassociation.org/priorities/patient-provider-protection): Engaging when state legislation, medical-board guidance, pharmacy-board policy, or other regulatory action may affect individualized care and independent clinical judgment. - [Compounding](https://personalizedhealthassociation.org/priorities/compounding): Supporting appropriate quality and safety standards while preserving lawful access to patient-specific compounded therapies. - [Regenerative Medicine](https://personalizedhealthassociation.org/priorities/regenerative-medicine): Advancing clear, responsible pathways for provider-directed regenerative care and patient access. - [Peptides & Emerging Therapies](https://personalizedhealthassociation.org/priorities/peptides): Addressing policy and regulatory issues that affect access to novel and individualized treatments as science and clinical practice evolve. - [Hormonal & Metabolic Health](https://personalizedhealthassociation.org/priorities/hormonal-health): Supporting modern, evidence-based standards for individualized hormonal and metabolic care. - [Clinical Research & Evidence](https://personalizedhealthassociation.org/priorities/clinical-research): Exploring modern approaches to physician-led research, real-world evidence, registries, and other methods of generating evidence in personalized medicine. ## Perspectives and announcements - [FDA Updates 503A Bulk Drug Substances Framework and Advances Review of Peptide Compounds](https://personalizedhealthassociation.org/articles/fda-updates-503a-bulk-drug-substances-framework-and-advances-review-of-peptide-compounds): The statement PHA issued on April 15, 2026, on FDA moving a group of peptide compounds toward formal advisory committee review. It names the substances involved and the expected timetable. - [Personalized Health Association (PHA) Launches to Advance Responsible Access to Personalized Medicine in the United States](https://personalizedhealthassociation.org/articles/pha-launches-to-advance-responsible-access-to-personalized-medicine-in-the-united-states): New National Organization Focuses on Modern Policy, Patient Access, and Safe Innovation - [Texas Federal Court Narrows Claims in Tirzepatide Dispute](https://personalizedhealthassociation.org/articles/texas-federal-court-narrows-claims-in-tirzepatide-dispute): The announcement PHA issued on December 22, 2025, on a Texas ruling that narrowed the claims against a compounding pharmacy over compounded tirzepatide. PHA's lead strategic advisor led the defense. - [Personalized Health Association Announces National Initiative to Modernize Stem Cell & Regenerative Medicine Policy](https://personalizedhealthassociation.org/articles/pha-announces-national-initiative-to-modernize-stem-cell-and-regenerative-medicine-policy): The announcement PHA issued on December 12, 2025, setting out its case for a cGMP-based federal pathway for certain adult stem cell products. It carries statements from PHA's founder, president and lead strategic advisor. - [Personalized Health Association (PHA) Launches to Expand Access to Personalized and Precision Healthcare Nationwide](https://personalizedhealthassociation.org/articles/pha-launches-to-expand-access-to-personalized-and-precision-healthcare-nationwide): The launch announcement PHA issued on November 24, 2025, naming the coalition behind it and its founding focus on physician autonomy and patient access. ## Events - [BEYOND Biohacking Conference 2027](https://personalizedhealthassociation.org/events/beyond-biohacking-2027): Dave Asprey's BEYOND Biohacking Conference, three days in Austin on longevity science, human performance and health technology. The 2026 edition drew more than five thousand attendees and over a hundred and fifty exhibitors. PHA will be there. - [LongevityFest 2026](https://personalizedhealthassociation.org/events/longevityfest-2026): A4M's longevity medicine conference, running December 11 to 13, 2026 at The Venetian Resort in Las Vegas. Three days of clinical programming on longevity medicine, aging science and integrative health. Registration is open to licensed professionals rather than the general public. - [Eudēmonia Summit 2026](https://personalizedhealthassociation.org/events/eudemonia-summit-2026): A four day gathering on health, well-being and longevity in downtown West Palm Beach, running November 5 to 8, 2026. It combines expert talks, movement and recovery sessions, and a health technology expo across the convention center and other venues nearby. - [Her Longevity Summit 2026](https://personalizedhealthassociation.org/events/her-longevity-summit-2026): A longevity medicine summit for women, led by longevity physicians. It runs in New York City on October 3, 2026, from 8:00 AM to 6:00 PM, and carries 8 CME credits. - [PepMed 2026: Regenerative Health World Congress](https://personalizedhealthassociation.org/events/pepmed-2026-regenerative-health-world-congress): The American Academy of Peptide Medicine's first Regenerative Health World Congress. Two days of scientific programming and policy discussion in Washington. PHA President Jimmy St. Louis is speaking on Performance, Recovery and Regeneration, on what peptides change for elite and everyday athletes.